Phase 1 trial of gene-editing therapy for hepatitis B cleared in US

Get Involved Trials, studies, surveys, and opportunities
2

Hi @Nass,
Thanks for sharing. This has been covered recently here:

First gene editing candidate for HBV

Precision BioSciences Announces Initial Safety and Antiviral Activity.

Both topics talks about the same company and product. Thanks, Bansah1

3 Likes